NEC Contributes to Development of Artificial DNA Aptamer that Binds to the Novel Coronavirus (SARS-CoV-2)
NEC Contributes to Development of Artificial DNA Aptamer that Binds to the Novel Coronavirus (SARS-CoV-2) TOKYO, May 6, 2021 - (JCN Newswire) - NEC Corporation (TSE: 6701) and NEC Solution Innovators today announced the successful development of artificial DNA aptamers (1) that bind to the novel coronavirus (SARS-CoV-2). This breakthrough stems from the NEC Group's efforts to promote spatial monitoring business using aptamers, including the development of new biosensing systems, such as measuring equipment that can monitor spaces where various viruses, including SARS-CoV-2 and influenza virus...
Source: finanznachrichten.de